InvestorsHub Logo
Followers 20
Posts 456
Boards Moderated 0
Alias Born 10/27/2012

Re: None

Wednesday, 03/16/2016 7:32:23 AM

Wednesday, March 16, 2016 7:32:23 AM

Post# of 3839
Presentation: http://wsw.com/webcast/roth30/galt/index.aspx

September will bring data on the NASH FX and Psoriasis GT-030.

Recent publication in Newsweek jan 2016.

Discussion on the Gilead Simtuzumab.

20$ cost a dose (very cheap).

Liver Multiscan to be used in the test - improvement from biopsy.

Cash might last until early next year - by which time, good top line results from either test might fetch better valuations.

This one needs patience.

And lose some weight. You dont want to be GALT client.

:)


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News